Literature DB >> 9125645

Serum beta2-microglobulin in chronic hepatitis C.

M Malaguarnera1, S Restuccia, I Di Fazio, A M Zoccolo, B A Trovato, G Pistone.   

Abstract

beta2-Microglobulin (beta2-MG) plays a key role in influencing the immune response to viral infections as it is an integrating part of the main histocompatibility system (HLA). We attempted to evaluate the changes in class I HLA antigens by comparing the serum beta2-MG behavior in a group of patients affected by chronic hepatitis C with that observed in a group of healthy controls. Our study revealed that the patients presented higher serum beta2-MG levels than healthy controls (P = 0.0003). beta2-MG levels were correlated with duration and degree of the disease. Furthermore, there was a statistically significant correlation between beta2-MG and HCV RNA levels, while no correlations were observed between serum beta2-MG levels and HCV genotypes. The increment in serum beta2-MG values accompanying the progression of liver disease may be an expression of augmented production rather than altered excretion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9125645     DOI: 10.1023/a:1018855928753

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

Review 1.  The regulation of expression of major histocompatibility complex products.

Authors:  P F Halloran; A Wadgymar; P Autenried
Journal:  Transplantation       Date:  1986-04       Impact factor: 4.939

2.  Expression of HLA class I antigens on hepatocytes in liver disease.

Authors:  T Fukusato; M A Gerber; S N Thung; S Ferrone; F Schaffner
Journal:  Am J Pathol       Date:  1986-05       Impact factor: 4.307

3.  HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection.

Authors:  M Pignatelli; J Waters; D Brown; A Lever; S Iwarson; Z Schaff; R Gerety; H C Thomas
Journal:  Hepatology       Date:  1986 May-Jun       Impact factor: 17.425

4.  In-vitro cell-mediated cytotoxicity for autologous liver cells in chronic non-A, non-B hepatitis.

Authors:  M Mondelli; A Alberti; F Tremolada; R Williams; A L Eddleston; G Realdi
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

5.  A study of HL-A antigens in human organs.

Authors:  M Berah; J Hors; J Dausset
Journal:  Transplantation       Date:  1970-03       Impact factor: 4.939

6.  HLA today.

Authors:  W F Bodmer
Journal:  Hum Immunol       Date:  1986-12       Impact factor: 2.850

7.  The detailed distribution of HLA-A, B, C antigens in normal human organs.

Authors:  A S Daar; S V Fuggle; J W Fabre; A Ting; P J Morris
Journal:  Transplantation       Date:  1984-09       Impact factor: 4.939

8.  Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells.

Authors:  M Zijlstra; M Bix; N E Simister; J M Loring; D H Raulet; R Jaenisch
Journal:  Nature       Date:  1990-04-19       Impact factor: 49.962

9.  Expression of a novel activation antigen on intrahepatic CD8+ T lymphocytes in viral chronic active hepatitis.

Authors:  C García-Monzón; R Moreno-Otero; J M Pajares; A García-Sánchez; M López-Botet; M O de Landázuri; F Sánchez-Madrid
Journal:  Gastroenterology       Date:  1990-04       Impact factor: 22.682

10.  Effect of interferon alpha, gamma, and tumor necrosis factor alpha on the HLA-A, B, C expression of cell lines derived from human liver.

Authors:  K Yoshioka; S Kakumu; H Tahara; M Arao; A Fuji
Journal:  Liver       Date:  1989-02
View more
  10 in total

Review 1.  Serum markers of hepatocellular carcinoma.

Authors:  Giulia Malaguarnera; Maria Giordano; Isabella Paladina; Massimiliano Berretta; Alessandro Cappellani; Mariano Malaguarnera
Journal:  Dig Dis Sci       Date:  2010-03-26       Impact factor: 3.199

2.  Relationship between serum b2-microglobulin levels and virological breakthrough in HBeAg-negative chronic hepatitis B patients, under long-term treatment schedules including lamivudine.

Authors:  Ioannis-S Elefsiniotis; Antonios Moulakakis; Konstantinos-D Pantazis; Irene Glynou; Ioannis Ketikoglou; Elena Vezali; Helen Kada; Epameinondas Tsianos
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

3.  Structural insights into the pre-amyloid tetramer of β-2-microglobulin from covalent labeling and mass spectrometry.

Authors:  Vanessa Leah Mendoza; Mario A Barón-Rodríguez; Cristian Blanco; Richard W Vachet
Journal:  Biochemistry       Date:  2011-07-08       Impact factor: 3.162

4.  Increased β-Sheet Dynamics and D-E Loop Repositioning Are Necessary for Cu(II)-Induced Amyloid Formation by β-2-Microglobulin.

Authors:  Nicholas B Borotto; Zhe Zhang; Jia Dong; Brittney Burant; Richard W Vachet
Journal:  Biochemistry       Date:  2017-02-16       Impact factor: 3.162

5.  Influence of hepatitis C virus coinfection on failure of HIV-infected patients receiving highly active antiretroviral therapy to achieve normal serum beta2microglobulin levels.

Authors:  J A García-García; J A Mira; J Fernández-Rivera; A J Ramos; J Vargas; J Macías; J A Pineda
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-01       Impact factor: 3.267

6.  Structure of the preamyloid dimer of beta-2-microglobulin from covalent labeling and mass spectrometry.

Authors:  Vanessa Leah Mendoza; Kwasi Antwi; Mario A Barón-Rodríguez; Cristian Blanco; Richard W Vachet
Journal:  Biochemistry       Date:  2010-02-23       Impact factor: 3.162

7.  Delineating the conformational elements responsible for Cu(2+)-induced oligomerization of beta-2 microglobulin.

Authors:  Dorottya V Blaho; Andrew D Miranker
Journal:  Biochemistry       Date:  2009-07-21       Impact factor: 3.162

8.  Metal binding sheds light on mechanisms of amyloid assembly.

Authors:  Matthew F Calabrese; Andrew D Miranker
Journal:  Prion       Date:  2009-01-28       Impact factor: 3.931

9.  Unique effect of Cu(II) in the metal-induced amyloid formation of β-2-microglobulin.

Authors:  Jia Dong; Crisjoe A Joseph; Nicholas B Borotto; Vanessa L Gill; Michael J Maroney; Richard W Vachet
Journal:  Biochemistry       Date:  2014-02-21       Impact factor: 3.162

10.  Evaluation of salivary beta-2 microglobulin as HBV proliferation marker in HBS Ag(+), HBV DNA PCR(+) and HBV DNA PCR(-) subjects.

Authors:  Hamidreza Abdolsamadi; Peiman Eini; Negin Ronasi; Seyed Alireza Kaboli; Mehrdad Hajilooei; Abbas MoghimBeigi; Poorandokht Davoudi; Fatemeh AhmadiMotemayel; Hamid Mohaghegh Shalmani
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.